Saline Solution: Clinical Trials

3,227 trials of Saline Solution, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1789 completed, 562 unknown, 250 terminated, 211 recruiting. 910 Not applicable, 797 Phase 2, 746 Phase 4, 575 Phase 3, 399 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable910Completed 505, Unknown 187, Not yet recruiting 61, Recruiting 47, Terminated 38, Withdrawn 34, Active not recruiting 24, Enrolling by invitation 8, Suspended 6
Phase 2797Completed 425, Unknown 119, Terminated 91, Recruiting 58, Withdrawn 41, Not yet recruiting 32, Active not recruiting 25, Enrolling by invitation 3, Suspended 3
Phase 4746Completed 410, Unknown 149, Terminated 52, Not yet recruiting 48, Recruiting 42, Withdrawn 27, Active not recruiting 10, Enrolling by invitation 5, Suspended 3
Phase 3575Completed 319, Unknown 88, Terminated 59, Recruiting 49, Not yet recruiting 22, Withdrawn 19, Active not recruiting 17, Suspended 2
Phase 1399Completed 234, Unknown 59, Terminated 29, Recruiting 27, Active not recruiting 17, Not yet recruiting 17, Withdrawn 16
Early Phase 180Completed 36, Unknown 18, Terminated 9, Recruiting 6, Withdrawn 4, Active not recruiting 2, Not yet recruiting 2, Suspended 2, Enrolling by invitation 1

Follow Saline Solution: new trials by email Literature Review of Saline Solution trials Research Report on Saline Solution

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ketamine and Midazolam Infusions for CRPS: Feasibility Study
Ketamine, Midazolam, Normal Saline - Complex Regional Pain Syndromes
Phase 2WithdrawnStanford University2099-01-012024-11-22
Postoperative Analgesia Using Ganglion Impar Block After Anal Surgery
Ganglion impar block with Bupivacaine., Ganglion impar block with normal saline - Postoperative Pain
Not applicableNot yet recruitingUniversity of Alexandria602028-07-012025-04-03
Magnesium Sulfate in Pediatric Burn Dressing Changes
magnesium sulfate, Normal Saline (0.9% NaCl) - Pediatric Burns
Phase 1Not yet recruitingHennepin Healthcare Research Institute102027-12-012026-10-09
A Study to Determine the Safety and Efficacy of TG-C in Subjects With Symptomatic Early Hip Osteoarthritis
TG-C, Placebo Control - Degenerative Osteoarthritis
Phase 2Not yet recruitingKolon TissueGene, Inc.2552027-10-012026-08-20
GV1001 Subcutaneous for the Treatment of Moderate to Severe Alzheimer's Disease(AD)
GV1001 Placebo, GV1001 1.12mg - Moderate to Severe Alzheimer's Disease
Phase 3Not yet recruitingSamsung Pharmaceutical Co., Ltd.7502027-07-012026-06-10
Adjuvant Therapeutic Cancer Vaccine (AST-201, pUMVC3-hIGFBP-2) in Patients With Advanced Ovarian Cancer
AST-201, Paclitaxel, Carboplatin - Advanced Ovarian Cancer
Phase 2Not yet recruitingAston Sci. Inc.982027-06-012026-10-27
Multicentric, Randomized Study to Assess Safety and Efficacy of Centhaquine in Patients With ARDS
Normal Saline, Centhaquine - Acute Respiratory Distress Syndrome (ARDS)
Phase 2Not yet recruitingPharmazz, Inc.802027-05-012026-09-17
Valproic AcId for Traumatic BRAin INjury Trial
Valproic Acid (VPA), Standard of care treatment + normal saline - Moderate Traumatic Brain Injury (TBI), Severe Traumatic Brain Injury
Phase 2 / Phase 3Not yet recruitingNorthwestern University4322027-05-012026-11-05
Challenge Trial of PfSPZ-LARC2 Vaccine in Burkina Faso
PfSPZ-LARC2 Vaccine, PfSPZ Challenge, Normal Saline - Malaria (Plasmodium Falciparum)
Phase 1Not yet recruitingSanaria Inc.452027-03-012026-07-31
A Study to Assess Safety and Efficacy of Centhaquine as a Resuscitative Agent
Normal Saline, Centhaquine - Hypovolemic Shock
Phase 3Not yet recruitingPharmazz, Inc.4302027-02-012026-09-17
Migraine Menopause Study
Eptinezumab 100 mg or Eptinezumab 300 mg administered intravenously in 100 mL saline solution, Placebo Normal Saline (NS) - Migraine, Menopausal
Phase 4Not yet recruitingAlberta Neurologic Centre1202027-02-012026-11-04
Umbilical Cord-derived Mesenchymal Stem Cell Injectables for the Regeneration of Partial-thickness Rotator Cuff Tears
umbilical cord-derived mesenchymal stem cell, Normal Saline - Rotator Cuff Disease
Not applicableNot yet recruitingKyoung Hwan Koh382027-02-012026-11-09
A Phase 1 Clinical Trial of Adjuvanted Protein-based HCV Vaccine Candidates (HCV Vaccine Trial)
AVIHepC1, Normal Saline - Hepatitis C
Phase 1Not yet recruitingUniversity of Alberta272027-01-152026-09-25
Study of DWP450 in Japanese Subjects With Glabellar Lines
DWP450 20 U, 0.9% Saline Solution 0.5 mL - Glabellar Lines
Phase 3Not yet recruitingDaewoong Pharmaceutical Co. LTD.1202027-01-012026-08-26
Effect Of Intracuff Dexamethasone On Postoperative Sore Throat In Patients Undergoing Laparoscopic Cholecystectomy
Dexamethasone (0.1 mg/kg), Normal Saline (0.9% NaCl) - Postoperative Sore Throat, Cough, Hoarseness
Not applicableNot yet recruitingB.P. Koirala Institute of Health Sciences402027-01-012026-08-24
Nebulised Colistimethate Sodium to Prevent Pediatric Ventilator-associated Pneumonia
colistimethate sodium, 0.9% Saline - Ventilator Associated Pneumonia
Phase 2 / Phase 3Not yet recruitingUniversity Hospital Fattouma Bourguiba4002027-01-012026-10-08
Lumbar Drain With Intrathecal Nicardipine in Aneurysmal Subarachnoid Hemorrhage
Normal Saline, Nicardipine - Subarachnoid Hemorrhage
Phase 4Not yet recruitingWake Forest University Health Sciences2142027-01-012026-10-01
DEXmedetomidine for Postoperative Analgesia and Delirium Prevention After NEUROsurgery (DEX-NEURO Trial)
Dexmedetomidine, Normal Saline (0.9% NaCl) - Neurosurgery, Brain Cancer
Not applicableNot yet recruitingUniversity of Malaya602027-01-012026-11-05
Estimates of the Efficacy of Talineuren (TLN) and Placebo in Patients With Parkinson Disease
Talineuren, Placebo - Parkinson Disease
Phase 2Not yet recruitingInnoMedica Schweiz AG402027-01-012026-10-30
Intravenous LIGNOcaine for the POstoperative Sore Throat
Intravenous lignocaine, Normal Saline (0.9% NaCl) - Postoperative Sore Throat, Cough, Hoarseness, Postoperative Complications
Phase 4Not yet recruitingUniversity of Malaya3982027-01-012026-11-13

Showing 20 of 3227. Sign in to see all of them.

Conditions studied

Pain, Postoperative (193)  ·  Pain (148)  ·  Agnosia (91)  ·  COVID-19 (73)  ·  Emergence Delirium (56)  ·  Acute Kidney Injury (47)  ·  Hemorrhage (46)  ·  Sepsis (43)  ·  Osteoarthritis (40)  ·  Shock, Septic (39)  ·  Postoperative Nausea and Vomiting (38)  ·  Osteoarthritis, Knee (37)  ·  Breast Neoplasms (32)  ·  Obesity (32)  ·  Stroke (30)

Sponsors

Assiut University (70)  ·  Yonsei University (47)  ·  Seoul National University Hospital (42)  ·  Peking University First Hospital (38)  ·  Allergan (34)  ·  Cairo University (34)  ·  Ain Shams University (33)  ·  Tanta University (25)  ·  Merck Sharp & Dohme LLC (21)  ·  Mahidol University (20)  ·  Northwestern University (20)  ·  General Hospital of Ningxia Medical University (19)  ·  Sanaria Inc. (19)  ·  Mayo Clinic (18)  ·  Chang Gung Memorial Hospital (17)

Countries

United States (986)  ·  China (385)  ·  South Korea (245)  ·  Canada (237)  ·  Egypt (222)  ·  United Kingdom (100)  ·  Taiwan (94)  ·  France (88)  ·  Australia (86)  ·  Germany (79)  ·  Italy (76)  ·  Brazil (71)  ·  Spain (71)  ·  Turkey (Türkiye) (71)  ·  Poland (62)

Top investigators

Dong-Xin Wang, MD, PhD (28)  ·  Yung-Tsan Wu, MD (8)  ·  Dong-Xin Wang, MD,PhD (6)  ·  Guolin Wang (6)  ·  Omar Soliman, MD (6)  ·  Guolin Wang, MD (5)  ·  Patrick E Duffy, M.D. (5)  ·  Xiaochun Zheng, MD (5)  ·  Jenny Low, MBBS (4)  ·  Michael W Donnino, MD (4)

Results publications

PMID 39428602, PMID 34473343, PMID 38063346, PMID 39301879, PMID 33990512, PMID 37870112, PMID 38757725, PMID 41604274, PMID 16275600, PMID 16324031, PMID 18809959, PMID 19411668, PMID 19478674, PMID 19802513, PMID 20027030, PMID 21300053, PMID 21623291, PMID 21670611, PMID 21675055, PMID 22939099, PMID 23371895, PMID 23741350, PMID 24052307, PMID 24754838, PMID 25072443, PMID 25184864, PMID 25288099, PMID 25336707, PMID 25932413, PMID 25971957, PMID 26220293, PMID 26231052, PMID 26305798, PMID 26706294, PMID 26807124, PMID 27488394, PMID 28183547, PMID 28279391, PMID 28302179, PMID 28369198, PMID 28778254, PMID 29253090, PMID 29485925, PMID 29784145, PMID 30116551, PMID 30339737, PMID 30524702, PMID 30957581, PMID 32187462, PMID 32665528

NIH funding

2015 (14), 2016 (12), 2019 (11), 2014 (10), 2017 (9), 2018 (8), 2023 (7), U01HL077863 (5), 2025 (4), 2008 (2), 2009 (2), K23DA029609 (2), U01AI131310 (2), 1UG3HL147011-01A1 (1), 2005 (1)